Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Prana Bio Ltd Ads S1 (NASDAQ: PRAN)

$2.89 USD $0.00 (0.00%)
Last Price $2.89
Net Change $0 (0%)
Bid $1.5
Ask Price $3.98
Open Price $2.85
Previous Close Price $2.89
High Price $2.89
Low Price $2.85
Number of Trades 43
Volume 16,600
Fifty Two Week High $6.69 (2016-08-08)
Fifty Two Week Low $1.52 (2016-12-23)
Average Daily Volume 248,187
Share Outstanding 8,900 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-233.33
Recent Earnings $
Annual EPS $0
Last Quarter EPS $
Market Capitalization $0.03B
Insider Shareholders % 0.388%
Annual Revenue $0B
No. Shares Outstanding 8,900
Inst. Shareholder % 2.36%
Annual Net Income $0B
TTM Net Profit Margin $100
1-Year Return -27.39%
3-Year Return -73.68%
5-Year Return -69.9%
5-Year Revenue Growth 2280%
5-Year Earnings Growth -59.62%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -233.330002%
Dividends per Share $
Stock Split Ratio 1-6
Beta 0
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.